Tag: retinitis pigmentosa
IDT Australia secures $3.2M manufacturing contract for investigational eye therapy
ASX-listed IDT Australia Limited has been awarded a five-year contract valued at $3.2 million for the manufacture of NPI-001 tablets, an investigational treatment for retinitis pigmentosa (RP), a degenerative eye disease that can lead to vision loss.
Featured Article
Delivering growth: how invoice finance transformed a logistics business
For a smaller freight-forwarding company to compete with international behemoths, Global Trade Logistics founder Gary Coutsoudis knows he and his team must outperform.
